{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:12:29Z","timestamp":1793059949356,"version":"4.5.0"},"reference-count":43,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec><jats:title>Importance<\/jats:title><jats:p>Adrenal venous sampling (AVS) is usually recommended to distinguish between unilateral and bilateral primary aldosteronism (PA) before definitive surgical or medical treatment is offered. Whether a treatment decision based on AVS with or without corticotropin (ACTH) stimulation leads to different biochemical and clinical remission rates in patients with PA remains unclear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To evaluate whether treatment decisions based on AVS with or without ACTH stimulation lead to different biochemical and clinical remission rates in patients with PA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This randomized clinical trial (RCT) was conducted at a tertiary hospital in China from July 8, 2020, to February 20, 2023, among patients with PA aged 18 to 70 years. Patients were followed up for 12 months after the initiation of treatment. An intention-to-diagnose analysis was conducted.<\/jats:p><\/jats:sec><jats:sec><jats:title>Interventions<\/jats:title><jats:p>Patients were randomly assigned to undergo either ACTH-stimulated or non\u2013ACTH-stimulated AVS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>The primary end point was the proportion of patients with complete biochemical remission after 12 months of follow-up. Secondary outcomes included the proportion of patients who achieved complete clinical remission after 12 months of follow-up, dosages of antihypertensive agents, rate of successful bilateral AVS, and adverse events.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 228 patients with PA, 115 were randomized to the non\u2013ACTH-stimulated group (median age, 50.0 years [IQR, 41.0-57.0 years]; 70 males [60.9%]) and 113 to the ACTH-stimulated group (median age, 50.0 years [IQR, 43.5-56.5 years]; 63 males [55.8%]). A total of 68 patients (59.1%) underwent adrenalectomy in the non-ACTH group and 65 (57.5%) in the ACTH group. There was no significant difference in the proportion of patients with complete biochemical remission who were managed on the basis of AVS with vs without ACTH stimulation (with: 56 of 113 [49.6%]; without: 59 of 115 [51.3%]; <jats:italic>P<\/jats:italic>\u2009=\u2009.79). There also was no significant difference in the proportion of patients who achieved complete clinical remission between the non-ACTH and ACTH groups (26 of 115 [22.6%] and 31 of 113 [27.4%], respectively; <jats:italic>P<\/jats:italic>\u2009=\u2009.40). The intensity of therapy with antihypertensives, successful catheterization of bilateral adrenal veins, and incidence of adverse events did not significantly differ between the non-ACTH and ACTH groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions and Relevance<\/jats:title><jats:p>In this RCT, treatment of PA on the basis of non\u2013ACTH-stimulated or ACTH-stimulated AVS did not lead to significant differences in clinical outcomes for the patients. These results suggest that ACTH stimulation during AVS may not have clinical benefit, at least in the Chinese population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial Registration<\/jats:title><jats:p>ClinicalTrials.gov Identifier: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.clinicaltrials.gov\/study\/NCT04461535\">NCT04461535<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.38209","type":"journal-article","created":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T15:01:11Z","timestamp":1698073271000},"page":"e2338209","source":"Crossref","is-referenced-by-count":28,"title":["Corticotropin Stimulation in Adrenal Venous Sampling for Patients With Primary Aldosteronism"],"prefix":"10.1001","volume":"6","author":[{"given":"Shumin","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xizi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianna","family":"Zhen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Shu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Beijing Chao-yang Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Medicine, Monash University, Clayton, Victoria, Australia"},{"name":"Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbo","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Chongqing Primary Aldosteronism Study (CONPASS) Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Mei","sequence":"additional","affiliation":[{"name":"for the Chongqing Primary Aldosteronism Study (CONPASS) Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suxin","family":"Luo","sequence":"additional","affiliation":[{"name":"for the Chongqing Primary Aldosteronism Study (CONPASS) Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangla","family":"Liao","sequence":"additional","affiliation":[{"name":"for the Chongqing Primary Aldosteronism Study (CONPASS) Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhang","sequence":"additional","affiliation":[{"name":"for the Chongqing Primary Aldosteronism Study (CONPASS) Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"He","sequence":"additional","affiliation":[{"name":"for the Chongqing Primary Aldosteronism Study (CONPASS) Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihong","family":"He","sequence":"additional","affiliation":[{"name":"for the Chongqing Primary Aldosteronism Study (CONPASS) Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Xiao","sequence":"additional","affiliation":[{"name":"for the Chongqing Primary Aldosteronism Study (CONPASS) Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Peng","sequence":"additional","affiliation":[{"name":"for the Chongqing Primary Aldosteronism Study (CONPASS) Group"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,10,23]]},"reference":[{"issue":"8","key":"zoi231122r1","doi-asserted-by":"publisher","first-page":"408","DOI":"10.5694\/mja2.v216.8","article-title":"Detecting primary aldosteronism in Australian primary care: a prospective study.","volume":"216","author":"Libianto","year":"2022","journal-title":"Med J Aust"},{"issue":"14","key":"zoi231122r2","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice.","volume":"69","author":"Monticone","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"zoi231122r3","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"zoi231122r4","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.jacc.2020.02.052","article-title":"Primary aldosteronism in patients in China with recently detected hypertension.","volume":"75","author":"Xu","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"zoi231122r5","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1161\/HYPERTENSIONAHA.118.11568","article-title":"Renal outcomes in medically and surgically treated primary aldosteronism.","volume":"72","author":"Hundemer","year":"2018","journal-title":"Hypertension"},{"issue":"8","key":"zoi231122r6","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1001\/jamacardio.2018.2003","article-title":"Incidence of atrial fibrillation and mineralocorticoid receptor activity in patients with medically and surgically treated primary aldosteronism.","volume":"3","author":"Hundemer","year":"2018","journal-title":"JAMA Cardiol"},{"key":"zoi231122r7","doi-asserted-by":"publisher","DOI":"10.1177\/14703203211003781","article-title":"Cardiovascular events and all-cause mortality in surgically or medically treated primary aldosteronism: a meta-analysis.","author":"Jing","year":"2021","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"7","key":"zoi231122r8","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1245\/s10434-013-2871-3","article-title":"Medical or surgical therapy for primary aldosteronism: post-treatment follow-up as a surrogate measure of comparative outcomes.","volume":"20","author":"Kline","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"zoi231122r9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis.","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"zoi231122r10","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1161\/HYPERTENSIONAHA.119.13463","article-title":"Clinical outcomes of 1625 patients with primary aldosteronism subtyped with adrenal vein sampling.","volume":"74","author":"Rossi","year":"2019","journal-title":"Hypertension"},{"issue":"5","key":"zoi231122r11","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline.","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"zoi231122r12","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1507\/endocrj.EJ21-0508","article-title":"Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021.","volume":"69","author":"Naruse","year":"2022","journal-title":"Endocr J"},{"key":"zoi231122r13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijchy.2020.100029","article-title":"The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism.","volume":"5","author":"Rossi","year":"2020","journal-title":"Int J Cardiol Hypertens"},{"issue":"4","key":"zoi231122r14","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/cen.v93.4","article-title":"Utility of adrenocorticotropic hormone in adrenal vein sampling despite the occurrence of discordant lateralization.","volume":"93","author":"Chee","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"zoi231122r15","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1210\/jc.2015-3915","article-title":"Basal and post-ACTH aldosterone and its ratios are useful during adrenal vein sampling in primary aldosteronism.","volume":"101","author":"El Ghorayeb","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"15","key":"zoi231122r16","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.clinbiochem.2013.04.004","article-title":"Adrenal vein sampling: substantial need for technical improvement at regional referral centres.","volume":"46","author":"Elliott","year":"2013","journal-title":"Clin Biochem"},{"issue":"6","key":"zoi231122r17","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.surg.2006.07.026","article-title":"Adrenal venous sampling in primary hyperaldosteronism: comparison of radiographic with biochemical success and the clinical decision-making with \u201cless than ideal\u201d testing.","volume":"140","author":"Harvey","year":"2006","journal-title":"Surgery"},{"issue":"4","key":"zoi231122r18","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1007\/s11255-008-9441-9","article-title":"Adrenal vein sampling may not be a gold-standard diagnostic test in primary aldosteronism: final diagnosis depends upon which interpretation rule is used: variable interpretation of adrenal vein sampling.","volume":"40","author":"Kline","year":"2008","journal-title":"Int Urol Nephrol"},{"issue":"4","key":"zoi231122r19","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1161\/HYPERTENSIONAHA.111.189548","article-title":"Effect of adrenocorticotropic hormone stimulation during adrenal vein sampling in primary aldosteronism.","volume":"59","author":"Monticone","year":"2012","journal-title":"Hypertension"},{"issue":"2","key":"zoi231122r20","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/01.hjh.0000202818.10459.96","article-title":"Dynamic testing with high-dose adrenocorticotrophic hormone does not improve lateralization of aldosterone oversecretion in primary aldosteronism patients.","volume":"24","author":"Rossi","year":"2006","journal-title":"J Hypertens"},{"issue":"5","key":"zoi231122r21","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1097\/HJH.0b013e3282f9e66a","article-title":"Adrenal vein sampling for primary aldosteronism: the assessment of selectivity and lateralization of aldosterone excess baseline and after adrenocorticotropic hormone (ACTH) stimulation.","volume":"26","author":"Rossi","year":"2008","journal-title":"J Hypertens"},{"issue":"6","key":"zoi231122r22","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz017","article-title":"Subtyping of primary aldosteronism in the AVIS-2 study: assessment of selectivity and lateralization.","volume":"105","author":"Rossitto","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"zoi231122r23","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1161\/HYPERTENSIONAHA.108.128553","article-title":"Adrenocorticotropic hormone stimulation during adrenal vein sampling for identifying surgically curable subtypes of primary aldosteronism: comparison of 3 different protocols.","volume":"53","author":"Seccia","year":"2009","journal-title":"Hypertension"},{"issue":"5","key":"zoi231122r24","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.3390\/jcm9051447","article-title":"Adrenal vein sampling to distinguish between unilateral and bilateral primary hyperaldosteronism: to ACTH stimulate or not?","volume":"9","author":"Sung","year":"2020","journal-title":"J Clin Med"},{"issue":"5","key":"zoi231122r25","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1097\/HJH.0000000000001964","article-title":"Impact of adrenocorticotropic hormone stimulation during adrenal venous sampling on outcomes of primary aldosteronism.","volume":"37","author":"Takeda","year":"2019","journal-title":"J Hypertens"},{"issue":"5","key":"zoi231122r26","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/cen.2016.85.issue-5","article-title":"Does ACTH improve the diagnostic performance of adrenal vein sampling for subtyping primary aldosteronism?","volume":"85","author":"Wolley","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"zoi231122r27","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/s41440-020-0445-x","article-title":"Cosyntropin stimulation in adrenal vein sampling improves the judgment of successful adrenal vein catheterization and outcome prediction for primary aldosteronism.","volume":"43","author":"Yatabe","year":"2020","journal-title":"Hypertens Res"},{"issue":"1","key":"zoi231122r28","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1161\/HYPERTENSIONAHA.121.17248","article-title":"Adrenocorticotropic hormone-stimulated adrenal venous sampling underestimates surgically curable primary aldosteronism: a retrospective cohort study and review of contemporary studies.","volume":"78","author":"Yozamp","year":"2021","journal-title":"Hypertension"},{"key":"zoi231122r29","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8647026","article-title":"Age-related cutoffs of plasma aldosterone\/renin concentration for primary aldosteronism screening.","volume":"2018","author":"Ma","year":"2018","journal-title":"Int J Endocrinol"},{"issue":"10","key":"zoi231122r30","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1097\/HJH.0000000000002510","article-title":"Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension.","volume":"38","author":"Mulatero","year":"2020","journal-title":"J Hypertens"},{"issue":"4","key":"zoi231122r31","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/S2213-8587(14)70069-5","article-title":"Adrenal vein sampling in primary aldosteronism: towards a standardised protocol.","volume":"3","author":"Monticone","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"zoi231122r32","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1161\/HYPERTENSIONAHA.113.02097","article-title":"An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism.","volume":"63","author":"Rossi","year":"2014","journal-title":"Hypertension"},{"key":"zoi231122r33","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.784706","article-title":"Comparison of bolus and continuous infusion of adrenocorticotropic hormone during adrenal vein sampling.","volume":"12","author":"Hu","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"zoi231122r34","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.surg.2015.06.048","article-title":"Diagnostic utility of data from adrenal venous sampling for primary aldosteronism despite failed cannulation of the right adrenal vein.","volume":"159","author":"Pasternak","year":"2016","journal-title":"Surgery"},{"issue":"9","key":"zoi231122r35","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort.","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"zoi231122r37","doi-asserted-by":"publisher","first-page":"5867","DOI":"10.1210\/jc.2019-01182","article-title":"Three discrete patterns of primary aldosteronism lateralization in response to cosyntropin during adrenal vein sampling.","volume":"104","author":"Wannachalee","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"zoi231122r38","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1530\/EJE-19-0860","article-title":"Effect of cosyntropin during adrenal venous sampling on subtype of primary aldosteronism: analysis of surgical outcome.","volume":"182","author":"Kobayashi","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"zoi231122r39","doi-asserted-by":"publisher","first-page":"E1089","DOI":"10.1210\/jc.2015-2149","article-title":"A meta-analysis of somatic KCNJ5 K(+) channel mutations in 1636 patients with an aldosterone-producing adenoma.","volume":"100","author":"Lenzini","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"zoi231122r40","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1210\/jc.2011-2885","article-title":"Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas.","volume":"97","author":"Taguchi","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"zoi231122r41","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1161\/HYPERTENSIONAHA.114.03346","article-title":"Clinical characteristics of somatic mutations in Chinese patients with aldosterone-producing adenoma.","volume":"65","author":"Zheng","year":"2015","journal-title":"Hypertension"},{"issue":"3","key":"zoi231122r42","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1097\/HJH.0000000000001578","article-title":"KCNJ5 mutation as a predictor for resolution of hypertension after surgical treatment of aldosterone-producing adenoma.","volume":"36","author":"Kitamoto","year":"2018","journal-title":"J Hypertens"},{"issue":"10","key":"zoi231122r43","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.1210\/jc.2019-00531","article-title":"KCNJ5 somatic mutation is a predictor of hypertension remission after adrenalectomy for unilateral primary aldosteronism.","volume":"104","author":"Vilela","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"zoi231122r36","unstructured":"International language for drug utilization research: ATC\/DDD. WHO Collaborating Centre for Drug Statistics Methodology (WHOCC). Updated August 22, 2023. Accessed March 6, 2023. https:\/\/www.whocc.no"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2810986\/yang_2023_oi_231122_1697472772.84384.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T15:01:16Z","timestamp":1698073276000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2810986"}},"subtitle":["The ADOPA Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2023,10,23]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.38209","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,23]]}}}